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Orexins are found to participate in mediating stress-induced drug relapse. However, the
neuroanatomical basis that orexin transmission modulates stress-induced drug seeking
remains unknown. The nucleus accumbens shell (NAcSh), best known for its role in
appetitive and negative motivation via dopamine receptors, is likely to be the potential
important brain area where the orexin system mediates stress-induced drug relapse since
the function of dopamine system in the NAcSh can be regulated by orexin transmission.
In the present study, a morphine conditioned place preference (CPP) model was used to
determine whether the two types of orexin receptors would be involved into footshock-
induced and/or drug priming-induced CPP reinstatement differentially. The results showed
that blockade of orexin-1 or orexin-2 receptor in the NAcSh significantly attenuated stress-
induced morphine CPP reinstatement, but neither of the orexin antagonists had any effect
on morphine priming-induced reinstatement. These findings indicate that the NAcSh is a
brain area through which orexins participate in stress but not drug priming-induced relapse
of opioid seeking.
Keywords: orexin, the nucleus accumbens shell, morphine, CPP, stress-induced reinstatement, drug priming-
induced reinstatement
INTRODUCTION
Orexins, including orexin A (OXA) and orexin B (OXB), are
neuropeptides derived exclusively from a small group of neurons
in the lateral and perifornical areas of the posterior hypothalamus.
They act at two receptor subtypes, orexin-1 receptor (OX1R) and
orexin-2 receptor (OX2R; de Lecea et al., 1998; Sakurai et al.,
1998). Despite having a restricted distribution, orexin neurons
project widely to many brain regions where orexins have been
implicated in feeding, sleep, arousal, and so on (Chemelli et al.,
1999; Sutcliffe and de Lecea, 2002; Taheri et al., 2002). Recently,
mounting evidence has shown that orexins are involved in dif-
ferent components of drug addiction (Plaza-Zabala et al., 2012),
including drug reward (Harris et al., 2005), drug reinforcement
(Espana et al., 2010), drug withdrawal (Georgescu et al., 2003)
and drug seeking behaviors (Boutrel et al., 2005). The specific
role of orexin receptors in drug reward and reinforcement remains
controversial (Borgland et al., 2006; Smith et al., 2009; Shoblock
et al., 2011; Voorhees and Cunningham, 2011; Plaza-Zabala et al.,
2012), but it is quite clear that the orexin system was involved
into different types of drug seeking induced by stress, cue and
context associated with drug reinforcement (Boutrel et al., 2005;
Dayas et al., 2008; Smith et al., 2010). It indicates that orexin
transmission may uniquely modulate drug relapse-like behaviors
but may not play a key role in the reinforcement of drugs of abuse
that maintains the ongoing drug taking behaviors.
The specific brain site which orexin transmission regulates
drug relapse has drawn dramatic attention. Ventral tegmental
area (VTA) is likely to be the most importantly potential
brain area since it receives heavy orexin fibers (Peyron et al.,
1998) and has been shown to express densely two types of
orexin receptors in dopamine neurons (Narita et al., 2006).
Moreover, electrophysiological evidence shows that orexin
applied to midbrain slices increases the VTA dopamine neurons
excitability (Korotkova et al., 2003), and intra-VTA infusion
of orexin stimulates dopamine release (Narita et al., 2006;
Vittoz and Berridge, 2006; Espana et al., 2010). Actually,
behavioral studies have shown that intra-VTA injection of
orexins reinstate the extinguished morphine and cocaine
preference (Harris et al., 2005; Wang et al., 2009), and
blockade of OX1R in the VTA attenuate cue-induced cocaine
reinstatement (James et al., 2011) but not stress-induced
cocaine reinstatement (Wang et al., 2009). This convincing
evidence indicates that VTA is the crucial brain structure at
which orexin transmission mediates cue-induced drug seeking
behaviors via transforming the environmental stimuli into
salient incentives (Stuber et al., 2008; Plaza-Zabala et al., 2012),
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whereas the brain site at which orexin system modulate stress
and drug priming-induced drug seeking behaviors remains to be
determined.
Recent studies have shown an important role of orexin trans-
mission in the stress regulation (Berridge et al., 2010; Lungwitz
et al., 2012); stress-related stimuli enhance the activity of orexin
neurons in the dorsal medial part of the hypothalamus (Harris
et al., 2005; Johnson et al., 2012), and central injections of orexins
increase the release of adrenocorticotrophic hormone (ACTH)
and corticosterone (Kuru et al., 2000; Samson et al., 2002) and
induce stress-like behaviors in rats (Li et al., 2010). Antagonism
of orexin receptors attenuates fear and anxiety-like behaviors
(Johnson et al., 2010; Li et al., 2010). Therefore, it is not surprising
that systemic blockade of OX1R prevented the stress-induced
cocaine reinstatement, and the cocaine reinstatement induced
by orexin injection is prevented by antagonism of noradrenergic
and corticotropin-releasing factor (CRF) systems (Boutrel et al.,
2005). However, to our knowledge, few studies have examined the
brain mechanisms by which orexin transmission regulates stress-
induced drug seeking behavior.
The nucleus accumbens (NAc), best known for its role in
mediating appetitive motivation related to drug relapse and aver-
sive motivation related to stress-like behaviors (Mcfarland and
Kalivas, 2001; Reynolds and Berridge, 2002; Mcfarland et al.,
2004), is likely to be the potential candidate at which the orexin
system may modulate stress-induced drug relapse. The NAc con-
sists of two subregions, referred to as the shell of the NAc (NAcSh)
and the core of the NAc (NAcC; Meredith, 1999). Anatomical
studies show that orexinergic fibers are mainly distributed in the
dorsomedial caudal part of the NAcSh (Baldo et al., 2003), the
unique area within the NAc that regulates stress-related behav-
iors via dopamine receptors (Faure et al., 2008; Richard and
Berridge, 2011). Interestingly, it is also found that the orexin fibers
intermingle heavily with dopamine fibers in the caudal NAcSh
(Baldo et al., 2003), indicating orexin transmission can modulate
dopamine release in this area. Indeed, an electrophysiological
study reveals that an interaction between the orexinergic and
dopaminergic systems occurs in the NAcSh, presumably via OX2R
(Mori et al., 2011), and intra-NAcSh injection of orexin increase
dopamine concentration in this area (Patyal et al., 2012). More
importantly, local injection of orexins in the NAcSh potentiated
and OX1R antagonist attenuated dopamine receptor agonist-
induced turning behaviors (Kotani et al., 2008). Dopamine D1
receptor in the NAcSh has been shown to participate in stress-
induced reinstatement (Shaham and Stewart, 1996; Shaham et al.,
2003; Mcfarland et al., 2004). Thus, it is reasonable to postulate
that the NAcSh is likely to be a potential brain area where orexin
transmission modulates the function of dopamine system to
participate in stress-induced reinstatement, and may also regulate
drug-primed reinstatement since the role of the NAcSh dopamine
receptor in drug priming-induced drug seeking behaivors has
been well established (Anderson et al., 2003; Bachtell et al., 2005;
Schmidt et al., 2006).
Both types of orexin receptors are reported to be expressed
in the NAcSh, where OX1R level is relatively lower than that of
OX2R (Marcus et al., 2001; Cluderay et al., 2002; Martin et al.,
2002). OX1R, which is selective for OXA, and OX2R, which is
nonselective for both OXA and OXB, are coupled to different G
proteins, which indicates that OX1R andOX2Rmay have different
functions (Sakurai et al., 1998; Zhu et al., 2003; Faedo et al.,
2012). Growing evidence has shown that OX1R signaling is more
involved in reward seeking, whereas OX2R signaling is involved in
arousal and stress-related behaviors (Lin et al., 1999; Willie et al.,
2003; Akanmu and Honda, 2005; Harris and Aston-Jones, 2006;
Dugovic et al., 2009; Smith et al., 2009; Wang et al., 2009; Plaza-
Zabala et al., 2012). It has been found that chronic drug exposure
causes long-lasting up-regulation of OX2R in the NAc (Zhang
et al., 2007), and orexin transmission mediates the function of
dopamine system in the NAcSh mostly via OX2R (Mori et al.,
2011). We speculate that stress and drug priming-induced drug
seeking behaviors may be modulated differentially by OX1R and
OX2R. Probably, OX2R would play a more important role in
the stress-induced reinstatement. In the present study, OX1R and
OX2R antagonists are locally injected into the NAcSh to examine
whether they modulate stress and/or drug priming-induced drug
relapse with an reinstatement paradigm, which is widely used in
the studies of drug relapse (Shaham et al., 2003).
MATERIALS AND METHODS
SUBJECTS
A total of 135 male Sprague-Dawley rats (Charles River, Beijing,
China) were used in these experiments. The rats were housed
individually in plastic cages on a 12 h light/12 h dark cycle (lights
on at 07:00) in a temperature and humidity-controlled colony
roomwith food and water available at all times. All the behavioral
tests were conducted during the light phase. The experimental
procedures followed the National Institutes of Health Guide for
Care and Use of Laboratory Animals (Publication No. 85–23,
revised 1985) and the experimental protocol was approved by
Research Ethics Review Board of Institute of Psychology, Chinese
Academy of Sciences.
SURGERY AND MORPHINE TREATMENT
After a week of acclimatization, rats were anesthetized with equi-
thesin (0.3 ml/100 g, i.p.) to implant stainless steel guide cannulas
(23 gauge, Plastics One, Roanoke, VA, USA) bilaterally into the
NAcSh (1.7 mm anterior to bregma, 0.8 mm bilateral to the
midline, and 5.5 mm ventral to the skull, with the incisor bar at
3.3 mm below intraaural line). Three stainless steel screws were
attached on the skull to anchor the guide cannula, and dental
cement was used to secure the guide cannulae in place. The
capped stylets (Plastics One, Roanoke, VA, USA) were inserted
to prevent occlusion. Then the rats were placed in their home
cages to recover for a week. Eight days after the surgery, the
rats were injected with escalating morphine doses 5.0 mg/kg,
10.0 mg/kg, 20.0 mg/kg, 30.0 mg/kg, 40.0 mg/kg and 50.0 mg/kg
(i.p.) for 6 days (each day with a different dose and each dose
was given twice a day) to induce drug dependence status (Li
et al., 2011). After the repeated morphine injection, the rats
went through 5 days abstinence periods in the home cages and
were handled for 5 min every day during the last 3 days of
the abstinence periods to acclimatize them to the experimenters’
manipulation.
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DRUGS AND MICROINJECTION
Morphine hydrochloride (Qinghai pharmaceutical, China),
SB334867, an OX1R antagonist (Tocris, U.K.), TCSOX229, an
OX2R antagonist (Tocris, U.K), DMSO (Sigma, U.S.) and saline
(NaCl 0.9%) were used in the experiments. Morphine (5.0
mg/ml, 3.0 mg/ml) and TCSOX229 (6.0 µg/µl, 20.0 µg/µl)
were dissolved in saline; SB334867 was dissolved in DMSO to
the concentration of 6.0 µg/µl, 20.0 µg/µl immediately before
use. Three days before the drug injection procedure, all the rats
were transferred to the behavioral test room and stayed there for
2 h and received mock microinjection daily to minimize stress.
During the microinjection period, each rat was gently held while
the stylet was removed. The drug or vehicle (0.5 µl) was injected
through an injector cannula (30 gauge, Plastics One, Roanoke,
VA, USA) which protruded 2.0 mm below the guide cannula tip.
An infusion pump mounted with a glass microsyringe was used
to deliver the drug at the rate of 0.2 µl/min over 2 min, and the
injector stayed in the guide cannula one more minute to prevent
fluid backflow.
CONDITIONED PLACE PREFERENCE (CPP) PROCEDURES
Apparatus
Seven identical black plastic boxes, measuring 80 × 40 × 50 cm
(L × W × H), were used for the Conditioned place preference
(CPP) test. The boxes were separated by a guillotine door into
two compartments with distinct visual and tactile cues. One side
had a dot floor with white horizontal stripes on the walls, and the
other side had a smooth floor with vertical stripes on the wall.
Behavioral procedures
The procedures consisted of four phases: adaptation, pretest,
conditioning and posttest. On day 1 (adaptation), the rats were
given access to the boxes for 15 min to reduce the novelty and
stress. During the pretest session (Day 2 and Day 3), the rats
were placed into the middle of the box and allowed to explore
freely. The time spent and distance travelled on both sides were
recorded for 15 min by a camera and analyzed by a computer with
professional software (Taiji Software Company, Beijing, China).
The average time spent in one compartment of the box both
days was used as the initial preference score; the pretest data
showed that most rats preferred the dot floor side. So a biased CPP
procedure was used in the conditioning phase in which the rats
received a morphine injection (5.0 mg/kg, i.p.) prior to placement
in their non-preferred chamber for 45 min in the morning, and
the same volume of saline in the reverse chamber in the afternoon
each day for 3 days. A 15min posttest expression session was done
after the conditioning, during which the rats could go through
the two chambers freely with the door open. The criterion for
the development of CPP is that the time spent in the morphine-
paired chamber was 100 s more than that in the pretest session.
Otherwise, they would receive two more morphine conditioning
sessions until the rats could reach the criterion. After acquisition
of morphine CPP, rats were given 9–12 extinction training ses-
sions with the same procedure like conditioning phase except that
saline was paired with each chamber. The 15 min posttest session
was done to assess the extinction effect. The extinction training
continued until the time spent in morphine paired side was at
least 80 s less than that during expression test.
Experimental design
Experiment 1: Effects of microinjection of the OX1R and OX2R
antagonists into the NAcSh on the footshock-induced reinstate-
ment of morphine CPP Six groups of rats (67 rats) were used in
the experiment. The control group (n= 11) received intra-NAcSh
vehicle injection without footshock, and another five groups
of rats received different doses of OX1R or OX2R antagonists
microinjection into the NAcSh (0.5 µl saline (n = 12), SB334867
(3.0µg/0.5µl, n= 11 and 10.0µg/0.5µl, n= 11) and TCSOX229
(3.0µg/0.5 µl, n= 11 and 10.0µg/0.5 µl, n= 11)) 15 min before
the footshock stress. The electrical footshock was administered as
previous studies (Wang et al., 2002, 2006). Briefly, the rats were
put into the shock chamber (22 × 22 × 16 cm, Med associates,
Inc., St. Albans, VT, USA) and received 15 min footshock (0.8
mA, 0.5 s) with an average 60 s interval. After the footshock
procedure, the rats were placed into the CPP box for 15 min
to assess the effect of footshock stress on the reinstatement of
morphine CPP.
Experiment 2: Effects of microinjection of the OX1R and OX2R
antagonists into the NAcSh on the morphine-induced reinstate-
ment of morphine CPP Another six groups of rats (68 rats) were
used in this experiment. The control group rats (n = 11) received
vehicle microinjection into the NAcSh and intraperitoneal saline
injection, the other five groups of rats received different doses
of OX1R or OX2R antagonists mincroinjection into NAcSh (0.5
µl saline (n = 11), SB334867 (3.0 ug/0.5 µl, n = 11 and 10.0
µg/0.5 µl, n = 11) and TCSOX229 (3.0 µg/0.5 µl, n = 12
and 10.0 µg/0.5 µl, n = 12)) 15 min before the morphine
challenge (3.0 mg/kg, i.p.). The rats were placed into the CPP
boxes for 15 min and allowed to explore freely to evaluate the
effect of morphine challenge injection on the reinstatement of
CPP.
CANNULA VERIFICATION
At the end of these experiments, the rats were deeply anesthetized
with chloral hydrate (40.0 mg/kg) and then perfused transcar-
dially with heparinized saline followed by 500 ml ice-cold 4.0%
paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.4). A
freezing microtome was used to get coronal sections from the
injection site at 40 µm. The brain slices were processed for cresyl
violet staining as previously done in our laboratory (Han et al.,
2010).
STATISTICAL ANALYSIS
The preference score (time spent in the morphine-paired side)
was analyzed by paired samples t test to assess the acquisition
and extinction of morphine CPP. The shift score (preference score
in reinstatement test minus preference score in extinction test)
among different drug treatment groups was analyzed by one-
way ANOVA. Post-hoc analysis with LSD test was employed to
determine if difference between groups was significant. All data
was shown as mean± SEM and analyzed with SPSS 16.0 software
for Windows.
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FIGURE 1 | All cannula placements in corresponding levels of the
NAcSh. Numbers to the left indicate the approximate rostrocaudal plane
posterior to bregma. Black dots show the location of the tip of the injector
cannula for the rats. The figure is adapted from diagrams of a stereotaxic
atlas of the rat brain (George Paxinos, 1996).
RESULTS
CANNULA VERIFICATION
Cannula placement was checked by postmortem histological ver-
ification. The rats with cannula placements within the following
coordinate scopes were used in the statistical analysis: 0.7 mm–1.7
mm anterior to bregma, 0.3 mm–1.6 mm bilateral to the midline,
and 6.2 mm–8.2 mm ventral to the skull (Figure 1). Thirteen rats
were removed because their placements were outside the scopes.
A representative photomicrograph of the microinjection sites was
presented in Figure 2.
ACQUISITION AND EXTINCTION OF MORPHINE INDUCED CPP
Paired samples t test showed that rats developed an obvious CPP
after 3–5 days of conditioning training, compared to their pretest
FIGURE 2 | Representative photomicrograph of the coronal section.
data (t(121) = 29.617, p < 0.0001, figure not shown). After
9–12 extinction training, the preference score significantly
decreased compared to the score measured in the expression test
(t(121) = 16.412, p < 0.0001, figure not shown). It suggested the
acquired CPP was obviously extinguished.
EXPERIMENT 1: OX1R OR OX2R ANTAGONIST INHIBITED THE
FOOTSHOCK-INDUCED REINSTATEMENT OF MORPHINE CPP
As depicted in Figures 3 and 4, independent samples t test
revealed that the rats receiving footshock stress spent more time
in the morphine-paired side compared to that in the nonshock
rats (t(13.716) = 2.264, p = 0.040), indicating a significant
reinstatement of morphine CPP. To examine the effect of OX1R or
OX2R antagonist on the footshock induced reinstatement, the rats
received two doses of SB334867 or TCSOX229microinjection into
the NAcSh. The one-way ANOVA revealed a significant difference
among the groups (F(2,24) = 4.475, p = 0.022), and the post-
hoc test suggested that the low dose of SB334867 (3 µg) blocked
the footshock-induced reinstatement (p = 0.007). A significant
difference was also found among the TCSOX229 groups and
vehicle group (F(2,26) = 4.210, p = 0.026) by the one-way
ANOVA, and the LSD test showed that the low dose of TCSOX229
(3 µg) also blocked the footshock-induced reinstatement (p =
0.012). Neither orexin receptor antagonists had any effect on
the locomotor activity (F(2,24) = 0.726, p = 0.494; F(2,26) =
0.091, p = 0.913). It suggested that the inhibition effect of OX2R
antagonist on the reinstatement was not caused by the motor
impairment.
EXPERIMENT 2: NEITHER OX1R NOR OX2R ANTAGONISTS HAD ANY
EFFECT ON MORPHINE-INDUCED REINSTATEMENT OF MORPHINE CPP
As shown in Figures 5 and 6, independent samples t test showed
a significant difference between the morphine priming group and
the control group (t(20) = 2.554, p = 0.019), indicating the
3.0 mg/kg (i.p.) morphine injection remarkably reinstated the
extinguished morphine CPP. To examine the effect of OX1R or
OX2R antagonist on the morphine-induced reinstatement, the
rats received two doses of SB334867 or TCSOX229microinjection
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FIGURE 3 | Effects of microinjections of vehicle (Veh), SB334867 (SB) at
3.0 or 10.0 µg (SB3 and SB10), or TCSOX229 (TCS) at 3.0 or 10.0 µg
(TCS3 and TCS10) in the NAcSh on footshock-induced reinstatement
of morphine CPP. *p < 0.05, the footshock group (FS + Veh) compared to
the control group non-footshock (NFS + Veh). #p < 0.05, ##p < 0.01,
compared to the FS + Veh. All data are expressed as mean ± SEM.
FIGURE 4 | Mean locomotor activity of all the groups in experiment 1.
All data are expressed as mean ± SEM.
into the NAcSh. One-way ANOVA demonstrated that neither
SB334867 (F(2,31) = 0.610, p = 0.550) nor TCSOX229 (F(2,31)
= 2.210, p= 0.127) had any effect on the reinstatement of CPP or
locomotor activity (F(2,31) = 0.199, p = 0.821; F(2,31) = 0.098,
p = 0.907).
DISCUSSION
Recent studies have demonstrated an important role for the
orexin system in relapse to drugs of abuse, especially to cocaine
and alcohol, but little is known about the role of orexins in opioid
relapse (Plaza-Zabala et al., 2012). In the present study, we found
that footshock stress and morphine challenge significantly rein-
stated the extinguished morphine CPP. The footshock-induced
reinstatement was attenuated by the blockade of OX1R or OX2R
in the NAcSh, but neither of these two orexin receptor antagonists
prevented morphine-induced reinstatement when injected in the
FIGURE 5 | Effects of microinjections of vehicle (Veh), SB334867 (SB) at
3.0 or 10.0 µg (SB3 and SB10), or TCSOX229 (TCS) at 3.0 or 10.0 µg
(TCS3 and TCS10) in the NAcSh on morphine-induced reinstatement
of morphine CPP. *p < 0.05, the morphine group (Mor + Veh) compared to
the control group (Sal + Veh). All data are expressed as mean ± SEM.
FIGURE 6 | Mean locomotor activity of all the groups in experiment 2.
All data are expressed as mean ± SEM.
NAcSh. These findings suggest that the NAcSh is a potential brain
site for orexin to mediate the stress-induced opioid relapse.
Besides its role in positive emotions, the NAcSh has also been
indicated in negative motivational states, such as fear, defensive
behavior and especially stress (Reynolds and Berridge, 2001).
Studies showed that many neurotransmitters (e.g., dopamine,
glutamate, 5-hydroxytryptamine (5-HT) and γ -aminobutyric
acid (GABA)) within the NAcSh mediated these negative
motivations (Inoue et al., 1994; Reynolds and Berridge, 2001;
Richard and Berridge, 2013). Our present study found that orexin
signaling in the NAcSh, including OX1R and OX2R, is also a
part of the neural mechanism of which the NAcSh participates in
stress-related behaviors. Consistent with our results, a previous
study showed that footshock stress was able to activate orexin
neurons and increase the release of orexin (DiLeone et al.,
2003).
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Previous studies showed that systemic injection of the
OX1R antagonist SB334867 attenuated footshock-induced
reinstatement of cocaine seeking (Boutrel et al., 2005), and
blockade of OX1R attenuate the reinstatement of alcohol seeking
caused by yohimbine, an α2 noradrenergic antagonist that
provokes a stress-like response (Richards et al., 2008). Whereas
another study found that SB334867 had no inhibitory effect
on footshock-induced reinstatement of nicotine seeking (Plaza-
Zabala et al., 2010), it suggests that the role of OX1R in the
stress-induced reinstatement is dependent on the types of abused
drugs. The role of OX1R in the stress-induced effects of opioids
(like morphine or heroin) reinstatement has not been reported
previously.
The specific brain site through which OX1R works on the
stress-induced reinstatement remains unknown. It was found
that intra-VTA administration of SB334867 had no effect on the
footshock-induced reinstatement of cocaine seeking (Wang et al.,
2009). Here, we found that infusion of the antagonists of OX1R
or OX2R into the NAcSh was able to prevent the footshock-
induced morphine CPP reinstatement. It suggests that orexin
signaling in the NAcSh is an important regulator to stress-induced
morphine reinstatement. Therefore, the NAcSh is a crucial brain
site through which OX1Rmodulates stress-induced reinstatement
of morphine-seeking behavior.
A few studies examined the role of OX2R in stress and stress-
induced relapse since the highly selective antagonist of the OX2R
was not available until recent years, except a recent study showed
that blockade of OX2R in the paraventricular nucleus of the thala-
mus (PVT) attenuated the anxiogenic states caused by a previous
exposure to footshock stress (Li et al., 2010). Previous evidence
showed that the NAcSh is an important brain site in footshock-
induced reinstatement, indicated by that transient inactivation
of the NAcSh blocked the footshock-induced reinstatement of
cocaine-seeking behavior (Mcfarland et al., 2004). Although little
is known about the receptor mechanisms underlying the NAcSh
contribution to the footshock-induced drug relapse, a potential
candidate is the dopamine system which is deeply involved in
reward and motivation, and footshock increases extracellular
dopamine in the NAcSh (Kalivas and Duffy, 1995; Pontieri et al.,
1995; Kelley, 2004). Actually, antagonism of dopamine D1-like
receptor in NAcSh but not in NAcC attenuated food-deprivation
stress-induced reinstatement of heroin seeking behaviors (Tobin
et al., 2013). As a main projection area of the orexin fibers, the
NAcSh is likely to be one of the most important candidate brain
areas where orexin may interact with dopamine to participate
in footshock-induced drug relapse. Firstly, orexin fibers inter-
mingled heavily with dopamine fibers within the caudal part of
the NAcSh (Baldo et al., 2003); secondly, OXB predominantly
excited the NAcSh neurons, and two-thirds of the neurons in
this area increased their firing rate to two times when OXB and
dopaminewere simultaneously applied (Mori et al., 2011); thirdly,
intra-NAcSh injection orexins increased dopamine concentration
(Patyal et al., 2012); lastly, local injection of orexins in the NAcSh
potentiated and OX1R antagonist attenuated dopamine recep-
tor agonist-induced turning behaviors (Kotani et al., 2008). So,
in the present study, it is likely that infusion of TCSOX229, a
selective antagonist of OX2R, into the NAcSh may attenuate the
ability of dopamine system to inhibit footshock-induced drug
relapse.
Surprisingly, our findings showed that lower dose (3 µg) but
not higher dose (10 µg) of OX1R or OX2R antagonist inhibited
the footshock-induced reinstatement of CPP. Consistent with our
results, a recent study also found that microinjection of lower dose
(0.1 µg ), but not higher dose (1.0 µg ) of OX1R antagonist into
the posterior part of the PVT decreased the stress-induced neuron
activation and ACTH response (Heydendael et al., 2011). One
potential interpretation for the negative effect of higher doses of
orexin receptor antagonists may be the unspecific effect resulting
from the relatively higher dose of the antagonists by binding to
other receptors. For example, a recent study showed that higher
dose of OX1R antagonist can act at 5HT2C (serotonin 2C) recep-
tors (Morairty et al., 2012). It has been established that blockade
of 5HT2C receptor is able to enhance cocaine reinstatement caused
by stress and 5HT2C agonist can attenuate drug seeking behaviors
(Neisewander and Acosta, 2007; Fletcher et al., 2008; Higgins
et al., 2012). In that case, higher dose of orexin antagonists
may act in two ways, blockade of orexin receptor will attenuate
the reinstatement, but on the other side, blockade of 5HT2C
receptor may enhance the reinstatement, therefore, it may be the
possible reason that no effect of higher dose of orexin antagonists
on the CPP reinstatement was observed in the present study.
But further experiments are needed to examine whether 5HT2C
receptor is involved into the negative effect on the stress-induced
morphine reinstatement by higher dose of orexin antagonists. It
is also helpful for us to understand the pharmacological profile
of orexin receptor antagonists with a third dose in the future
studies.
Growing evidence has shown that there is functional differ-
ence between OX1R and OX2R, such as their different G pro-
tein coupling mechanisms, brain area distribution and ligand
selectivity (Sakurai et al., 1998; Marcus et al., 2001; Zhu et al.,
2003; Faedo et al., 2012). Signaling at OX1R is hypothesized
to be primarily involved in reward-seeking behaviors based on
the finding that cocaine-seeking was reinstated by local VTA
microinjection of OXA but not OXB (Wang et al., 2009). OX1R
signaling was also indicated to be involved in cue and context-
induced reinstatement of cocaine seeking, while the antagonist of
OX2R cannot block cue-induced cocaine seeking (Smith et al.,
2009, 2010). Nevertheless, OX2R signaling is hypothesized to
be related to arousal functions of the orexin system based on
the finding that loss of the OX2R signaling is associated with
symptoms of narcolepsy in animals (Lin et al., 1999; Willie et al.,
2003; Akanmu and Honda, 2005; Dugovic et al., 2009). Since
arousal is important for stress response, OX2R may participate in
stress response and stress-induced reinstatement of drug-seeking
behaviors. Here our study found that OX2R signaling was neces-
sary for footshock-induced reinstatement of an extinguishedmor-
phine CPP. But we did not find a functional difference between
OX1R and OX2R in footshock-induced reinstatement of opioid-
seeking at the level of the NAcSh, since both of them worked
on it.
Our results demonstrate that antagonism of neither of these
two receptors in the NAcSh could block morphine-primed rein-
statement. Consistent with our finding, a recent study found that
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OX1R signaling was unnecessary for cocaine-primed reinstate-
ment of cocaine seeking (Aston-Jones et al., 2010). But little is
known about the role of the OX2R signaling in drug-primed
reinstatement. The neural mechanisms of the drug priming-
induced reinstatement, which concerns many neurotransmitter
systems, e.g., dopamine, glutamate, 5-HT and GABA, are very
complicated and require further investigation (Shaham et al.,
2003).
In conclusion, the NAcSh is probably an important part of the
neural circuit where orexins exert a pivotal modulation of stress-
induced reinstatement of opioid seeking behavior, but it may not
be a critical brain site where orexin participates in drug-primed
reinstatement of opioid seeking.
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